Since joining the Global Health Program at the Bill & Melinda Gates Foundation, Dr Margaret Liu has been working closely with organizations all over the world to facilitate their efforts in getting vaccines made and distributed. Bringing with her many years of experience in vaccine development in the industrial sector, Liu is "excited about being at an organization that has really helped to catalyze a change in the whole mentality about vaccines."
"As a researcher trying to develop a vaccine you hope that you can improve peoples' lives. It can be frustrating to feel that the priorities of prevention are so low on the radar screen that with more adequate resources and attention so much more could be done," says Liu. The Bill & Melinda Gates Foundation, currently the largest charitable foundation in the world, has put vaccines high on its list of priorities.
To date the foundation has invested over $1 billion in vaccine development and immunization programs. The foundation's approach has been to support very focused approaches to vaccine development and to give large sums to get the job done. The largest donation to date has been to the Global Fund for Children's Vaccines to support the immunization of children in developing countries through the purchase of new and under-used vaccines: the foundation's pledge stands at $750 million over the next five years.
The foundation supports mainly diseases that are neglected by commercial entities. "A goodly number of critical diseases are being addressed, and diseases that do not command global attention but which are devastating in a number of developing countries, are now receiving attention," says Liu. For example, one applied research program, currently financed by the foundation to the tune of $40 million is called Disease of the Most Impoverished (DOMI). DOMI is based at the new International Vaccine Institute in Seoul, Korea. The foundation's funds will be used for the development and introduction of vaccines against cholera, dysentery, and typhoid.
Another example was the announcement in January of a $100 million donation to the International Aids Vaccine Initiative (IAVI) for the development of an AIDS vaccine. The vaccine is one of many AIDS vaccines being tested on humans around the world but the first to target the 'A' strain of the HIV virus, which is prevalent in subSaharan Africa.
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Raising the priorities of disease prevention
The Bill & Melinda Gates Foundation -the software billionaire's charity -recently appointed Margaret Liu as its senior advisor for vaccinology. She tells Laura Bonetta about some of the foundation's plans.
are encountered in the context of vaccine efforts. These include safety, stability at room temperature, and removing the need for devices to deliver a vaccine. And to increase the number of children who are immunized, it is important to develop vaccines that can be administered at birth or that condense doses into one so that children are not lost to follow up.
The foundation's work is notable not only because of the huge sums of the donations but also because it has helped to galvanize other public and private sector efforts. One example was the White House summit held in March 2000 with the heads of the big vaccine companies. At the meeting, former president Clinton revealed that he was seeking from Congress a contribution to the Global Fund for Children's Vaccines but also tax credits for companies prepared to invest in this general area and in other aspects of health in the developing world.
Liu works closely with the foundation's grantees. She sees her role as 'helping grantees get what they need to get the job done'. It seems a perfect fit for Liu who, before her appointment, was a scientific advisor at the International Vaccine Institute in Seoul and a medical advisor for the Global Fund for Children's Vaccines. In addition to overseeing the foundation's vaccine work, Liu assists organizations like the World Health Organization (WHO) with vaccinerelated activities.
Liu is also one of a handful of advisors who evaluate proposals that are submitted to the foundation. While the foundation considers unsolicited proposals, Liu cautions that "it is better to call and talk to someone first."
When asked about working with Bill Gates, Liu praised his and his wife's involvement and commitment. "They read about the issues, ask questions, visit sites," says Liu.
Liu joined the foundation in October 2000. Previously, she was vice president of vaccine research and gene therapy at Chiron Corporation and a senior director at Merck & Co. And Liu spends 25% of her time working at Transgene -a French-based company. As Transgene's research interests are in the gene therapy area, neither Liu nor the foundation perceive a conflict. Liu says her position at Transgene allows her to maintain a close contact with the whole research and development process.
Laura Bonetta is a freelance science writer based in the Washington DC area.
